vor 5 Jahren

EMA macht Risiko-Analyse zu Astrazenca-Impfstoff

AMSTERDAM (dpa-AFX) - Im Zusammenhang mit seltenen Fällen von Hirnthrombosen nach einer AstraZeneca-Impfung plant die Europäische Arzneimittelbehörde EMA nun eine Analyse zu Risiken und Nutzen des Corona-Impfstoffs. Dies teilte die Behörde am Mittwoch in Amsterdam nach einem Treffen der EU-Gesundheitsminister mit. Überprüft werden sollen die...

Quelle: Börse Online RSS Feed

Does running Lightning Network actually feel worth the added complexity for everyday small transactions, or does on-chain still win for most practical use?vor 8 Stunden
When they tell you "don't trust, verify"vor 9 Stunden
I classified 551 wallet-recovery questions on Bitcoin Stack Exchange. Only 5 were about losing a seed word.vor 9 Stunden
Bitstamp: Important update — new crypto deposit rejection rules effective August 18, 2026vor 9 Stunden
Why not Bitcoin Cash and/ or BSVvor 10 Stunden
Biblically accurate Assumption of Redditors about Bitcoinvor 10 Stunden
Wonder who they got that fromvor 16 Stunden
Boltz shut down all Bitcoin swap services on August 3, saying attackers now iterate faster than a small team can patch. It's the clearest AI-vs-defense story I've seen in this space yet.vor 16 Stunden
If Bitcoin doesn’t hit $420,069 by December 31, 2033, I’ll eat a Carolina Reaper on January 1, 2034 and post the evidence herevor 16 Stunden
after bip-110 failed to get miner support, bip-54 (timewarp attack fix) is next upvor 18 Stunden